FIA
REGN icon

Foundations Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Foundations Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Buy
+293
New +$224K ﹤0.01% 1051
2021
Q4 		– Sell
-616
Closed -$339K – 353
2021
Q3 		$339K Buy
616
+121
+24% +$75.1K 0.01% 236
2021
Q2 		$287K Buy
+495
New +$251K 0.01% 245

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Foundations Investment Advisors's REGN Position: Q1 2026 in Review

Foundations Investment Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 293 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1051 among its holdings. This is a return to the name: Foundations Investment Advisors previously reported a position in REGN as recently as Q3 2021.

Foundations Investment Advisors first reported a position in REGN in Q2 2021 and has held it in 3 quarters since. The position peaked at $339K in Q3 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Foundations Investment Advisors held 293 shares of Regeneron Pharmaceuticals worth $226K as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Foundations Investment Advisors position in Q1 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q1 2026, its #1051 holding.
  • Foundations Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • Foundations Investment Advisors's Regeneron Pharmaceuticals position peaked at $339K in Q3 2021.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.